These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 6097565

  • 1. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
    Chemke J, Lieberman E, Carmi R, Abarbanel Y, Costeff H, Goldhammer Y, Moser HW.
    Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
    [Abstract] [Full Text] [Related]

  • 2. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
    Moser HW, Moser AB, Kawamura N, Murphy J, Suzuki K, Schaumburg H, Kishimoto Y.
    Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
    [Abstract] [Full Text] [Related]

  • 3. [Adrenoleukodystrophy and adrenomyeloneuropathy. Clinical spectrum, electrophysiologic and biochemical findings in 4 families].
    Klemm E, Zierz S.
    Nervenarzt; 1990 Apr; 61(4):219-24. PubMed ID: 2162008
    [No Abstract] [Full Text] [Related]

  • 4. [Familial adrenoleukodystrophy].
    Le Fur JM, Le Meur F, Parent P, Toudic L, Castel Y.
    J Genet Hum; 1985 Dec; 33(5):427-34. PubMed ID: 4093772
    [Abstract] [Full Text] [Related]

  • 5. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.
    Moser AB, Borel J, Odone A, Naidu S, Cornblath D, Sanders DB, Moser HW.
    Ann Neurol; 1987 Mar; 21(3):240-9. PubMed ID: 2440378
    [Abstract] [Full Text] [Related]

  • 6. Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.
    Cotrufo R, Melone MA, Monsurro MR, Di Iorio G, Carella C, Moser HW.
    Am J Med Genet; 1987 Apr; 26(4):833-8. PubMed ID: 3591825
    [Abstract] [Full Text] [Related]

  • 7. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy.
    Deon M, Sitta A, Barschak AG, Coelho DM, Terroso T, Schmitt GO, Wanderley HY, Jardim LB, Giugliani R, Wajner M, Vargas CR.
    J Neurol Sci; 2008 Mar 15; 266(1-2):79-83. PubMed ID: 17915255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Adrenoleukomyeloneuropathy. A familial case].
    Gastaut JL, Pellissier JF, Pfister B, Figarella-Branger D, Michel B.
    Rev Neurol (Paris); 1988 Mar 15; 144(5):338-46. PubMed ID: 3420352
    [Abstract] [Full Text] [Related]

  • 10. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
    Moser HW, Moser AE, Singh I, O'Neill BP.
    Ann Neurol; 1984 Dec 15; 16(6):628-41. PubMed ID: 6524872
    [Abstract] [Full Text] [Related]

  • 11. Linkage of DNA markers at Xq28 to adrenoleukodystrophy and adrenomyeloneuropathy present within the same family.
    Willems PJ, Vits L, Wanders RJ, Coucke PJ, Van der Auwera BJ, Van Elsen AF, Raeymaekers P, Van Broeckhoven C, Schutgens RB, Dacremont G.
    Arch Neurol; 1990 Jun 15; 47(6):665-9. PubMed ID: 2161209
    [Abstract] [Full Text] [Related]

  • 12. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.
    Rizzo WB, Phillips MW, Dammann AL, Leshner RT, Jennings SS, Avigan J, Proud VK.
    Ann Neurol; 1987 Mar 15; 21(3):232-9. PubMed ID: 3037987
    [Abstract] [Full Text] [Related]

  • 13. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
    Deon M, Wajner M, Sirtori LR, Fitarelli D, Coelho DM, Sitta A, Barschak AG, Ferreira GC, Haeser A, Giugliani R, Vargas CR.
    J Neurol Sci; 2006 Sep 25; 247(2):157-64. PubMed ID: 16750542
    [Abstract] [Full Text] [Related]

  • 14. [Adult disclosure of a case of familial adrenoleukodystrophy].
    Turpin JC, Paturneau-Jouas M, Sereni C, Pluot M, Baumann N.
    Rev Neurol (Paris); 1985 Sep 25; 141(4):289-95. PubMed ID: 2990005
    [Abstract] [Full Text] [Related]

  • 15. Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex).
    Powers JM.
    Clin Neuropathol; 1985 Sep 25; 4(5):181-99. PubMed ID: 2998664
    [Abstract] [Full Text] [Related]

  • 16. [Adrenoleukodystrophy and adrenomyeloneuropathy--clinical spectrum, pathobiochemical aspects, diagnosis and therapy].
    Zierz S, Tackmann W.
    Fortschr Neurol Psychiatr; 1989 Dec 25; 57(12):527-34. PubMed ID: 2559009
    [Abstract] [Full Text] [Related]

  • 17. [X-linked adrenoleukodystrophy--case reports of 4 patients in a family].
    Dumić M, Ille J, Fumić K, Kacić-Milicić Z, Cvitanović M, Plavsić V, Spehar A, Janjanin N, Filipović-Grcić B.
    Lijec Vjesn; 2002 Dec 25; 124(8-9):258-62. PubMed ID: 12587436
    [Abstract] [Full Text] [Related]

  • 18. [X-linked adrenoleukodystrophy].
    Aubourg P.
    Ann Endocrinol (Paris); 2007 Dec 25; 68(6):403-11. PubMed ID: 17532287
    [Abstract] [Full Text] [Related]

  • 19. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
    Singh I, Moser AE, Moser HW, Kishimoto Y.
    Pediatr Res; 1984 Mar 25; 18(3):286-90. PubMed ID: 6728562
    [Abstract] [Full Text] [Related]

  • 20. [X-linked adrenoleukodystrophy--2 case reports].
    Dumić M, Ille J, Plavsić V, Filipović-Grcić B, Vrljicak K, Barisić N, Roscher A.
    Lijec Vjesn; 1998 Mar 25; 120(1-2):19-23. PubMed ID: 9650481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.